-
1
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
2
-
-
0036984640
-
Role of angiogenesis in tumor growth and metastasis
-
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18.
-
(2002)
Semin Oncol
, vol.29
, pp. 15-18
-
-
Folkman, J.1
-
3
-
-
84859575611
-
Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
-
Shojaei F (2012) Anti-angiogenesis therapy in cancer: Current challenges and future perspectives. Cancer Lett 320: 130-137.
-
(2012)
Cancer Lett
, vol.320
, pp. 130-137
-
-
Shojaei, F.1
-
4
-
-
0034031079
-
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
-
Eggert A, Ikegaki N, Kwiatkowski J, Zhao HQ, Brodeur GM, et al. (2000) High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6: 1900-1908.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1900-1908
-
-
Eggert, A.1
Ikegaki, N.2
Kwiatkowski, J.3
Zhao, H.Q.4
Brodeur, G.M.5
-
5
-
-
0034693879
-
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
-
Karkkainen MJ, Petrova TV (2000) Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19: 5598-5605.
-
(2000)
Oncogene
, vol.19
, pp. 5598-5605
-
-
Karkkainen, M.J.1
Petrova, T.V.2
-
7
-
-
34548443831
-
Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
-
Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19: 2003-2012.
-
(2007)
Cell Signal
, vol.19
, pp. 2003-2012
-
-
Holmes, K.1
Roberts, O.L.2
Thomas, A.M.3
Cross, M.J.4
-
8
-
-
79957902010
-
Signal transduction by vascular endothelial growth factor receptors
-
Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437: 169-183.
-
(2011)
Biochem J
, vol.437
, pp. 169-183
-
-
Koch, S.1
Tugues, S.2
Li, X.3
Gualandi, L.4
Claesson-Welsh, L.5
-
9
-
-
0035895711
-
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
-
Zachary I, Gliki G (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49: 568-581.
-
(2001)
Cardiovasc Res
, vol.49
, pp. 568-581
-
-
Zachary, I.1
Gliki, G.2
-
10
-
-
0034615992
-
Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase
-
Rousseau S, Houle F, Kotanides H, Witte L, Waltenberger J, et al. (2000) Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 275: 10661-10672.
-
(2000)
J Biol Chem
, vol.275
, pp. 10661-10672
-
-
Rousseau, S.1
Houle, F.2
Kotanides, H.3
Witte, L.4
Waltenberger, J.5
-
11
-
-
0033538057
-
The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling
-
Thakker GD, Hajjar DP, Muller WA, Rosengart TK (1999) The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 274: 10002-10007.
-
(1999)
J Biol Chem
, vol.274
, pp. 10002-10007
-
-
Thakker, G.D.1
Hajjar, D.P.2
Muller, W.A.3
Rosengart, T.K.4
-
12
-
-
0032500505
-
Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation
-
Pedram A, Razandi M, Levin ER (1998) Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273: 26722-22678.
-
(1998)
J Biol Chem
, vol.273
, pp. 26722-122678
-
-
Pedram, A.1
Razandi, M.2
Levin, E.R.3
-
13
-
-
83255162010
-
Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
-
Takahashi S (2011) Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy. Biol Pharm Bull 34: 1785-1788.
-
(2011)
Biol Pharm Bull
, vol.34
, pp. 1785-1788
-
-
Takahashi, S.1
-
14
-
-
20644432867
-
Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
-
Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, et al. (2005) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23: 3502-3508.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3502-3508
-
-
Hurwitz, H.I.1
Fehrenbacher, L.2
Hainsworth, J.D.3
Heim, W.4
Berlin, J.5
-
15
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
-
16
-
-
84859892839
-
A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis
-
Kankanala J, Latham AM, Johnson AP, Homer-Vanniasinkam S, Fishwick CWG, et al. (2012) A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis. Br J Pharmacol 166: 737-748.
-
(2012)
Br J Pharmacol
, vol.166
, pp. 737-748
-
-
Kankanala, J.1
Latham, A.M.2
Johnson, A.P.3
Homer-Vanniasinkam, S.4
Fishwick, C.W.G.5
-
17
-
-
17044420935
-
Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects
-
Tong Y, Zhang X, Tian F, Yi Y, Xu Q, et al. (2005) Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects. Int J Cancer 114: 843-853.
-
(2005)
Int J Cancer
, vol.114
, pp. 843-853
-
-
Tong, Y.1
Zhang, X.2
Tian, F.3
Yi, Y.4
Xu, Q.5
-
18
-
-
73449089468
-
Triptolide functions as a potent angiogenesis inhibitor
-
He MF, Huang YH, Wu LW, Ge W, Shaw PC, et al. (2010) Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer 126: 266-278.
-
(2010)
Int J Cancer
, vol.126
, pp. 266-278
-
-
He, M.F.1
Huang, Y.H.2
Wu, L.W.3
Ge, W.4
Shaw, P.C.5
-
19
-
-
84863021288
-
Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
-
Lai L, Liu J, Zhai D, Lin Q, He L, et al. (2012) Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Br J Pharmacol 165: 1084-1096.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 1084-1096
-
-
Lai, L.1
Liu, J.2
Zhai, D.3
Lin, Q.4
He, L.5
-
20
-
-
84863000261
-
Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation
-
Mu X, Shi W, Sun L, Li H, Jiang Z, et al. (2012) Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation. Molecules 17: 6854-6868.
-
(2012)
Molecules
, vol.17
, pp. 6854-6868
-
-
Mu, X.1
Shi, W.2
Sun, L.3
Li, H.4
Jiang, Z.5
-
21
-
-
0018699757
-
The antimicrobial specificity of tryptanthrin
-
Honda G, Tabata M, Tsuda M (1979) The antimicrobial specificity of tryptanthrin. Planta Med 37: 172-174.
-
(1979)
Planta Med
, vol.37
, pp. 172-174
-
-
Honda, G.1
Tabata, M.2
Tsuda, M.3
-
22
-
-
67651124638
-
Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils
-
Lin YK, Leu YL, Huang TH, Wu YH, Chung PJ, et al. (2009) Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils. J Ethnopharmacol 125: 51-58.
-
(2009)
J Ethnopharmacol
, vol.125
, pp. 51-58
-
-
Lin, Y.K.1
Leu, Y.L.2
Huang, T.H.3
Wu, Y.H.4
Chung, P.J.5
-
23
-
-
33744930621
-
Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis tinctoria extracts and tryptanthrin
-
Recio MC, Cerda-Nicolas M, Potterat O, Hamburger M, Rios JL (2006) Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis tinctoria extracts and tryptanthrin. Planta Medica 72: 539-546.
-
(2006)
Planta Medica
, vol.72
, pp. 539-546
-
-
Recio, M.C.1
Cerda-Nicolas, M.2
Potterat, O.3
Hamburger, M.4
Rios, J.L.5
-
24
-
-
0034950115
-
Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour
-
Kimoto T, Hino K, Koya-Miyata S, Yamamoto Y, Takeuchi M, et al. (2001) Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour. Pathol Int 51: 315-325.
-
(2001)
Pathol Int
, vol.51
, pp. 315-325
-
-
Kimoto, T.1
Hino, K.2
Koya-Miyata, S.3
Yamamoto, Y.4
Takeuchi, M.5
-
25
-
-
34248186686
-
Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells
-
Yu ST, Chen TM, Tseng SY, Chen YH (2007) Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem Biophys Res Commun 358: 79-84.
-
(2007)
Biochem Biophys Res Commun
, vol.358
, pp. 79-84
-
-
Yu, S.T.1
Chen, T.M.2
Tseng, S.Y.3
Chen, Y.H.4
-
26
-
-
70350754348
-
Modulatory effects and action mechanisms of tryptanthrin on murine myeloid leukemia cells
-
Chan HL, Yip HY, Mak NK, Leung KN (2009) Modulatory effects and action mechanisms of tryptanthrin on murine myeloid leukemia cells. Cell Mol Immunol 6: 335-342.
-
(2009)
Cell Mol Immunol
, vol.6
, pp. 335-342
-
-
Chan, H.L.1
Yip, H.Y.2
Mak, N.K.3
Leung, K.N.4
-
27
-
-
84875969300
-
Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells
-
Liao XM, Leung KN (2013) Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells. Chem Biol Interact 203: 512-521.
-
(2013)
Chem Biol Interact
, vol.203
, pp. 512-521
-
-
Liao, X.M.1
Leung, K.N.2
-
28
-
-
80052038008
-
Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo
-
Chan JYW, Koon JCM, Liu XZ, Detmar M, Yu BA, et al. (2011) Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo. J Ethnopharmacol 137: 64-69.
-
(2011)
J Ethnopharmacol
, vol.137
, pp. 64-69
-
-
Chan, J.Y.W.1
Koon, J.C.M.2
Liu, X.Z.3
Detmar, M.4
Yu, B.A.5
-
29
-
-
84856092388
-
An indirubin derivative, E804, exhibits potent angiosuppressive activity
-
Chan YK, Kwok HH, Chan LS, Leung KS, Shi J, et al. (2012) An indirubin derivative, E804, exhibits potent angiosuppressive activity. Biochem Pharmacol 83: 598-607.
-
(2012)
Biochem Pharmacol
, vol.83
, pp. 598-607
-
-
Chan, Y.K.1
Kwok, H.H.2
Chan, L.S.3
Leung, K.S.4
Shi, J.5
-
30
-
-
76149120388
-
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
-
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461.
-
(2010)
J Comput Chem
, vol.31
, pp. 455-461
-
-
Trott, O.1
Olson, A.J.2
-
31
-
-
84873724973
-
Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes
-
Zhou X, Wang Y, Hu T, Or PM, Wong J, et al. (2013) Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes. Phytomedicine 20: 367-374.
-
(2013)
Phytomedicine
, vol.20
, pp. 367-374
-
-
Zhou, X.1
Wang, Y.2
Hu, T.3
Or, P.M.4
Wong, J.5
-
32
-
-
0030576517
-
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
-
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
-
(1996)
Cell
, vol.86
, pp. 353-364
-
-
Hanahan, D.1
Folkman, J.2
-
33
-
-
0026478824
-
Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro
-
Kaneko T, Nagata I, Miyamoto S, Kubo H, Kikuchi H, et al. (1992) Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro. Stroke 23: 1637-1642.
-
(1992)
Stroke
, vol.23
, pp. 1637-1642
-
-
Kaneko, T.1
Nagata, I.2
Miyamoto, S.3
Kubo, H.4
Kikuchi, H.5
-
34
-
-
77957841701
-
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
-
Lee K, Jeong KW, Lee Y, Song JY, Kim MS, et al. (2010) Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. Eur J Med Chem 45: 5420-5427.
-
(2010)
Eur J Med Chem
, vol.45
, pp. 5420-5427
-
-
Lee, K.1
Jeong, K.W.2
Lee, Y.3
Song, J.Y.4
Kim, M.S.5
-
35
-
-
84860394704
-
Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells
-
Zhu X, Zhang X, Ma G, Yan J, Wang H, et al. (2011) Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. J Pharm Pharm Sci 14: 325-335.
-
(2011)
J Pharm Pharm Sci
, vol.14
, pp. 325-335
-
-
Zhu, X.1
Zhang, X.2
Ma, G.3
Yan, J.4
Wang, H.5
-
36
-
-
0026677532
-
HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
-
Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690.
-
(1992)
J Invest Dermatol
, vol.99
, pp. 683-690
-
-
Ades, E.W.1
Candal, F.J.2
Swerlick, R.A.3
George, V.G.4
Summers, S.5
-
37
-
-
1442334073
-
Comparison of angiogenic potential of human microvascular endothelial cells and human umbilical vein endothelial cells
-
Nanobashvili J, Jozkowicz A, Neumayer C, Fügl A, Sporn E, et al. (2003) Comparison of angiogenic potential of human microvascular endothelial cells and human umbilical vein endothelial cells. Eur Surg 35: 214-218.
-
(2003)
Eur Surg
, vol.35
, pp. 214-218
-
-
Nanobashvili, J.1
Jozkowicz, A.2
Neumayer, C.3
Fügl, A.4
Sporn, E.5
-
38
-
-
0030448814
-
Blood vessel formation: What is its molecular basis?
-
Folkman J, D'Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155.
-
(1996)
Cell
, vol.87
, pp. 1153-1155
-
-
Folkman, J.1
D'Amore, P.A.2
-
39
-
-
0037275772
-
Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay
-
Cattaneo MG, Pola S, Deho V, Sanguini AM, Vicentini LM (2003) Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay. Br J Pharmacol 138: 377-385.
-
(2003)
Br J Pharmacol
, vol.138
, pp. 377-385
-
-
Cattaneo, M.G.1
Pola, S.2
Deho, V.3
Sanguini, A.M.4
Vicentini, L.M.5
-
40
-
-
0030480322
-
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
-
Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
-
(1996)
Cell
, vol.87
, pp. 1171-1180
-
-
Suri, C.1
Jones, P.F.2
Patan, S.3
Bartunkova, S.4
Maisonpierre, P.C.5
-
41
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
-
Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
-
(1997)
Science
, vol.277
, pp. 55-60
-
-
Maisonpierre, P.C.1
Suri, C.2
Jones, P.F.3
Bartunkova, S.4
Wiegand, S.J.5
-
42
-
-
0024501976
-
The effects of platelet-derived growth factor in cultured microvessel endothelial cells
-
Bar RS, Boes M, Booth BA, Dake BL, Henley S, et al. (1989) The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124: 1841-1848.
-
(1989)
Endocrinology
, vol.124
, pp. 1841-1848
-
-
Bar, R.S.1
Boes, M.2
Booth, B.A.3
Dake, B.L.4
Henley, S.5
-
43
-
-
0027082937
-
Platelet-derived growth factor is angiogenic in vivo
-
Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, et al. (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7: 261-266.
-
(1992)
Growth Factors
, vol.7
, pp. 261-266
-
-
Risau, W.1
Drexler, H.2
Mironov, V.3
Smits, A.4
Siegbahn, A.5
-
44
-
-
0034076189
-
Mechanisms of angiogenesis and arteriogenesis
-
Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
-
(2000)
Nat Med
, vol.6
, pp. 389-395
-
-
Carmeliet, P.1
-
45
-
-
0030758669
-
Tryptanthrins: A novel class of agonists of the aryl hydrocarbon receptor
-
Schrenk D, Riebniger D, Till M, Vetter S, Fiedler HP (1997) Tryptanthrins: A novel class of agonists of the aryl hydrocarbon receptor. Biochem Pharmacol 54: 165-171.
-
(1997)
Biochem Pharmacol
, vol.54
, pp. 165-171
-
-
Schrenk, D.1
Riebniger, D.2
Till, M.3
Vetter, S.4
Fiedler, H.P.5
-
46
-
-
31744449858
-
Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective
-
Paz K, Zhu Z (2005) Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective. Front Biosci 10: 1415-1439.
-
(2005)
Front Biosci
, vol.10
, pp. 1415-1439
-
-
Paz, K.1
Zhu, Z.2
-
47
-
-
81355124779
-
Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells
-
Yue GG, Fan JT, Lee JK, Zeng GZ, Ho TW, et al. (2011) Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells. Br J Pharmacol 164: 1883-1898.
-
(2011)
Br J Pharmacol
, vol.164
, pp. 1883-1898
-
-
Yue, G.G.1
Fan, J.T.2
Lee, J.K.3
Zeng, G.Z.4
Ho, T.W.5
-
48
-
-
0033103867
-
Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: A key enzyme in angiogenesis
-
McTigue MA, Wickersham JA, Pinko C, Showalter RE, Parast CV, et al. (1999) Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure 7: 319-330.
-
(1999)
Structure
, vol.7
, pp. 319-330
-
-
McTigue, M.A.1
Wickersham, J.A.2
Pinko, C.3
Showalter, R.E.4
Parast, C.V.5
-
49
-
-
1642323740
-
Protein kinase inhibitors: Insights into drug design from structure
-
Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303: 1800-1805.
-
(2004)
Science
, vol.303
, pp. 1800-1805
-
-
Noble, M.E.1
Endicott, J.A.2
Johnson, L.N.3
|